EazeBio Partners with UC Santa Cruz to Develop Instrument-Free Diagnostics
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
Read MorePosted by CLP Edit Staff | Oct 29, 2025 | Molecular Diagnostics, Point-of-Care |
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
Read MorePosted by CLP Edit Staff | Oct 28, 2025 | Tuberculosis |
Single-button device designed to streamline workflow for PCR tuberculosis diagnostics in resource-limited settings, with potential deployment across India’s primary health centers.
Read MorePosted by CLP Edit Staff | Oct 27, 2025 | Sexually Transmitted Diseases |
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
Read MorePosted by CLP Edit Staff | Oct 27, 2025 | Cancer |
The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Gastrointestinal Infections |
Deep-learning model trained on 4,000 samples shows 98.6% agreement with manual review while identifying additional organisms missed by technologists.
Read More